Literature DB >> 2998423

Cyclic AMP binding proteins in human breast cancer.

W R Miller, R O Senbanjo, J Telford, D M Watson.   

Abstract

The characteristics of a method for measuring cyclic AMP binding proteins in cytosols of human breast cancer are described. Using the assay, binding proteins were demonstrable in all of 100 tumour cytosols. Levels of binding in individual tumours varied from 0.8 to 15 pmol mg-1 cytosol protein (mean value 5 pmol mg-1 cytosol protein) and the dissociation constant ranged from 0.5 to 5.2 X 10(-8)M (mean 1.73 X 10(-8)M). Whilst replicate measurements within a single portion of tumour were reproducible (intra-assay coefficient of variation was between 4.5 and 7.8% and that for inter-assay variation was between 2.1 and 4.0%) there were often considerable differences in levels of binding proteins between different portions of the same tumour. Similar intra-tumour variations have been reported for other binding proteins and steroid receptors. The inter-relationships with such parameters may elucidate whether the differences are associated with variations in cellularity, cell type, or other specific factors.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2998423      PMCID: PMC1977260          DOI: 10.1038/bjc.1985.224

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  11 in total

1.  Antagonistic action between cyclic adenosine 3':5'-monophosphate and estrogen in rat mammary tumor growth control.

Authors:  Y S Cho-Chung
Journal:  Cancer Res       Date:  1978-11       Impact factor: 12.701

2.  Cyclic AMP-binding proteins: inverse relationship with estrogen-receptors in hormone-dependent mammary tumor regression.

Authors:  Y S Cho-Chung; J S Bodwin; T Clair
Journal:  Eur J Biochem       Date:  1978-05

3.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

4.  Intratumoral variation of cytoplasmic and nuclear estrogen receptor concentrations in human mammary carcinoma.

Authors:  C Silfverswärd; L Skoog; S Humla; S A Gustafsson; B Nordenskjöld
Journal:  Eur J Cancer       Date:  1980-01       Impact factor: 9.162

5.  Regression of hormone-dependent mammary tumors in Sprague-Dawley rats as a result of tamoxifen or pharmacologic doses of 17 beta-estradiol: cyclic adenosine 3',5'-monophosphate-mediated events.

Authors:  J S Bodwin; P H Hirayama; J A Rego; Y S Cho-Chung
Journal:  J Natl Cancer Inst       Date:  1981-02       Impact factor: 13.506

6.  Hypothesis. Cyclic AMP and its receptor protein in tumor growth regulation in vivo.

Authors:  Y S Cho-Chung
Journal:  J Cyclic Nucleotide Res       Date:  1980

7.  Relationship of hormone dependency to estrogen receptor and adenosine 3',5'-cyclic monophosphate-binding proteins in rat mammary tumors.

Authors:  J S Bodwin; T Clair; Y S Cho-Chung
Journal:  J Natl Cancer Inst       Date:  1980-02       Impact factor: 13.506

8.  Cyclic adenosine 3':5-monophosphate receptor proteins in hormone-dependent and -independent rat mammary tumors.

Authors:  Y S Cho-Chung; T Clair; M Schwimmer; L Steinberg; J Rego; F Grantham
Journal:  Cancer Res       Date:  1981-05       Impact factor: 12.701

9.  Relationship of cyclic AMP binding capacity and estrogen receptor to hormone sensitivity in human breast cancer.

Authors:  S Kvinnsland; R Ekanger; S O Døskeland; T Thorsen
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

10.  Reproducibility of measurements of oestrogen-receptor concentration in breast cancer.

Authors:  R A Hawkins; A Hill; B Freedman; S M Gore; M M Roberts; A P Forrest
Journal:  Br J Cancer       Date:  1977-09       Impact factor: 7.640

View more
  8 in total

1.  Tumour cyclic AMP binding proteins: an independent prognostic factor for disease recurrence and survival in breast cancer.

Authors:  W R Miller; D M Watson; W Jack; U Chetty; R A Elton
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

2.  Patterns of cyclic AMP binding in normal human breast.

Authors:  S Battersby; T J Anderson; W R Miller
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

3.  Cyclic AMP binding proteins and prognosis in breast cancer.

Authors:  W R Miller; R A Elton; J M Dixon; U Chetty; D M Watson
Journal:  Br J Cancer       Date:  1990-02       Impact factor: 7.640

4.  Variations in steroid receptors and cyclic AMP binding proteins across human breast cancers: evidence for heterogeneity.

Authors:  R O Senbanjo; W R Miller; R A Hawkins
Journal:  Br J Cancer       Date:  1986-07       Impact factor: 7.640

5.  Prospective evaluation of prognostic factors in operable breast cancer.

Authors:  R A Hawkins; A L Tesdale; M E Killen; W J Jack; U Chetty; J M Dixon; M J Hulme; R J Prescott; M A McIntyre; W R Miller
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

6.  Cyclic adenosine 3',5'-monophosphate-binding proteins in human ovarian cancers.

Authors:  A D Ramage; D J Burns; W R Miller
Journal:  Br J Cancer       Date:  1994-01       Impact factor: 7.640

7.  Differential expression of cAMP-kinase subunits is correlated with growth in rat mammary carcinomas and uterus.

Authors:  G Houge; Y S Cho-Chung; S O Døskeland
Journal:  Br J Cancer       Date:  1992-12       Impact factor: 7.640

8.  8-Chloro-cAMP induces apoptotic cell death in a human mammary carcinoma cell (MCF-7) line.

Authors:  R Bøe; B T Gjertsen; S O Døskeland; O K Vintermyr
Journal:  Br J Cancer       Date:  1995-11       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.